Arvind singh retweeted
Complete summary and more of IgA nephropathy using mass spectrometry.
1. Majority of IgA is IgA1.
2. Smaller amounts of IgA2 are also present.
3. Both IgA1 and IgA2 colocalize with IgG, showing that the deposits are composed of IgA1/IgG and IgA2/IgG.
4. Dominant IgG subclass is IgG1.
5. J chain that binds monomers of IgA into dimers is present in majority of cases, indicating that the IgA is mucosal derived (as circulating IgA is monomer and doesn’t have J chain)
6. Absence of PIGR indicates that IgA is not derived from secretions such as saliva, tears, etc. PIGR is a peptide in IgA (present in secretions), that prevent the breakdown of IgA by bacteria.
Taken together: IgA immune complexes in IgA nephropathy are made up of antigenic (galactose-deficient) mucosal-derived IgA and IgG.
7. Complement: Large amounts of C3 and C9 indicating alternative and terminal pathways of complement activation.
8. Minimal classical/no lectin pathway proteins.
9. Some correlation with MESTC score but bottom line= all IgA nephropathy shows lots of C3 and C9.
10. Abundant CFHR5 indicating that there is breakdown of C3 into inactive C3=iC3b.
11. Complement is a major player in the inflammatory process in IgA nephropathy.
kidney-international.org/art…
Nephrology for the non nephrologists. One not to miss @GlosPgme @GlosRenal
Arvind singh retweeted
Last week kicked off another year of the @GlomCon Glomerular Disease fellowship program 🎉
Watching it grow each year; more competitive applicants, close to 200 fellows educated annually; is a testament to the amazing community we’ve built: our #faculty, #instructors, program directors & associates.
Grateful doesn’t even cover it. 💙
#GlomCon #Nephrology #Education
@Nephronpower @jogameiro @s_almutar @poyanmehr
Arvind singh retweeted
Our PKD Medical Directorship Program had a fantastic year ❤️amazing feedback, real impact. Now we’re calling for our next cohort!
If you’re passionate about making a difference in #PKD care, we’d love to have you join us. Apply today 👇 @GlomCon
glomcon.org/pkdmd-program
@fouadchebib @pranavgarimella @ndahl48
Explore a new educational activity on shared decision-making for adults with C3 glomerulonephritis (C3GN): kdigo.co/C3GN-Shared-Decisio…
In this CME activity, @SaynaNorouzi shares patient-centered communication techniques through a clinical patient vignette.
Dr. Norouzi highlights treatment considerations, monitoring, vaccination review, and long-term kidney preservation goals to help align treatment decisions with patient priorities and lifestyle factors.
Arvind singh retweeted
Today we had an outstanding talk about clinical trials in ADPKD by Dr. @fouadchebib from Mayo Clinic Florida at @GlomCon PKD-MDP.
-Consideration for Tolvaptan initiation and referral for possible clinical trials.
-Key Milestones in ADPKD and clinical trials
Arvind singh retweeted
AI feedback vs. human feedback >> we put it to the test ⭐️
At @GlomCon Fellowship, we care about how we teach, not just what we teach. So we studied one of the most overlooked skills: giving great feedback.
See the details here👇
academic.oup.com/joneph/adva…
Arvind singh retweeted
A big thank you to everyone involved in South-West Glomerulonephritis Day – a fantastic event with valuable knowledge sharing, great conversations, and a shared focus on improving patient care. @gloshos_careers @Arvind__ @SWRenalNetwork @mattberesford92
Delighted to host 2nd South-West Glomerulonephritis Day.
A fantastic day of collaboration, networking, shared learning, and bringing colleagues together. Upwards & Onwards 🤝🫘
A big thank you to our amazing speakers, @GlosPgme @gloshospitals @SWRenalNetwork @mattberesford92
Arvind singh retweeted
We recently had a fantastic session on #PMN by @Ting2li @ShaneBobart @MadhuPotluri4 @GlomCon Fellowship program. I’m truly grateful for our amazing community; as we get together to learn, grow and also teach the next generation of experts 🥰⭐️ #Education #RareKidneyDisease #ClinicalTrials
Arvind singh retweeted
Our amazing Sol giving a talk on ADPKD based on her @TheLancet paper today at @GlomCon PKD fellowship
thelancet.com/journals/lance…
Arvind singh retweeted
Thrilled to have @Nefrontera as our speaker today in the @GlomCon PKD-MD Program presenting an updated review on ADPKD based on her recently published review article in @TheLancet
Link to article: thelancet.com/article/S0140-…
Arvind singh retweeted
Happy to chair the first-of-its-kind session on yoga's role in muscle & bone health at @iofbonehealth World Congress of Osteoporosis (#WCO2026) in Prague last evening!
Scientific analysis of yoga trials by Drs. Manju Chandran, Lakshmi Nagendra & Paras Bajaj, plus live demo!
Ancient Indian science of #Yoga boosts muscle strength, balance—and it's fun! Proud to showcase on global stage. 🇮🇳
@MoHFW_INDIA @DrJitendraSingh @PMOIndia
Managing glomerular disease in tropical regions require a specialized lens. Join #GlomConPH on April 22, 2026, for a high-impact workshop designed for physicians to master the nuances of tropical nephrology—from biopsy interpretation to navigating the latest KDIGO updates.
🤖 Made with AI
Arvind singh retweeted
Highly inspiring excellent talk by @PepaSolerR on increasing role of onconephrology in kidney patients care 💫 #GlomConEurope @GlomCon #GLOSEN @SENefrologia @ERAkidney @ClaraGCarro
Arvind singh retweeted
Wonderful session by Sjoerd Timmermans on the role of complement in glomerular diseases moderated by @PepaSolerR and Sofia Santos 💫 @JohannMorelle @AnnetteBruchfe1 @smirioglu @AKronbichler @StefanieSteige6 @anuja_java @KateIsabelle24 @ERAkidney #GlomConEurope @GlomCon
Arvind singh retweeted
Time for the last mini-orals session chaired by Sofia Homem de Melo Marquez and @Arvind__ #GlomConEurope @GlomCon
Arvind singh retweeted
Moving forward to a highly informative lecture by @hjanders_hans on Lupus Nephritis at #GlomconEurope
🚨 Do not introduce Lupus Nephritis as a Complex disease. It is our responsibility to treat this disease regardless of complexity!
@GlomCon
@GlomConPortugal
@jogameiro @SaynaNorouzi @Arvind__ @Nephr0s @IzabelaZakrocka
Arvind singh retweeted
Replying to @IgAN_JBarratt
@IgAN_JBarratt followed with an equally impressive lecture on IgA Nephropathy
#GlomConEurope
@GlomCon @GlomConPortugal
@jogameiro @Arvind__ @SaynaNorouzi @Nephr0s @IzabelaZakrocka
Despite the tsunami 🌊 of new drugs 💊💉 for IgAN, challenges still remain😰
@IgAN_JBarratt — the man, the myth, the legend gives a deeper dive into “From Mucosa to Kidney” in #IgAN.
Using Probiotics or removing the IgA any good in IgAN 🤔?? Watch this space 👀
#GlomConEurope























































